One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

From a talent perspective, the pharma and biotech industry is highly competitive, according to William Holodnak, the CEO and founder of life sciences recruitment firm Occam. He noted that clients ...

As well as identifying novel drug targets and therapeutics, the partnership will explore collaboration in R&D with leading academic and research organizations globally and support the development of ...

If India is looking at China for inspiration in the startup ecosystem, then it would be remiss not to also examine China’s strides in the biotechnology sector. The potential for growth and ...

Celebrities like Tom Brady and Tiger Woods support the project. The Dallas-based biotechnology firm, founded by Ben Lamm, has emerged as a trailblazer in de-extinction science. But Lamm is clear ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

A US congressional commission has urged lawmakers to take action to counter China’s “frightening” ascent in biotechnology, flagging Chinese firms including WuXi AppTec and BioMap ...

However, the prospect of future industry-specific tariffs could intensify selling pressure on biotech stocks. Despite the uncertainty, top hedge fund managers have invested millions of dollars in ...